Navigation Links
Controlling gait of horses may be possible, says key study from Texas A&M
Date:8/29/2012

COLLEGE STATION Aug. 29, 2012 Analysis of a specific mutation in a gene in horses that affects the ability of horses to use alternate gaits is strongly related to racing performance and is advantageous for harness-racing horses. In domestic horses, the mutation has had a major impact on their diversification, as the altered gait characteristics of a number of breeds apparently require this mutation, according to a study that includes a Texas A&M University researcher.

Gus Cothran, a professor in the Animal Genetic Lab of the College of Veterinary Medicine & Biomedical Sciences, is part of a team of researchers that examined motion in horses and also mice. Their findings are published in the current issue of Nature magazine.

Cothran and the team used a process called "whole genome SNP analysis" to study the genes of 70 Icelandic horses that had either four gaits or five, with the pace being the fifth gait. This pointed to a gene identified as DMRT3 that is critical for horse motion and limb movement.

They found that DMRT3 has a major impact on the movement of a horse, especially its gait. Horses have gaits classified in three descriptions of speed: walk, trot and gallop.

" 'Gaitedness' is a trait that naturally occurs in all horses, but many breeds have been developed for a specific speed or gait," Cothran explains.

The team sequenced the DMRT3 gene of the test horses and found that in almost every case of gaited horses, there was mutation in the DMRT3 that caused a premature "stop codon" which causes the protein product of the gene to be terminated before the whole protein is completed. This alters the function of the protein which leads to the differences associated with the gait.

Cothran and the team also examined the same gene and its effect on mice.

"We specifically looked at the gene and its effect on the movement of mice, such as its swimming ability," he adds.

"The motion ab
'/>"/>

Contact: Keith Randall
keith-randall@tamu.edu
979-845-4644
Texas A&M University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Controlling gene expression: How chromatin remodelers block a histone pass
2. Controlling gene expression with hydrogen peroxide switches
3. Controlling inflammatory and immune responses
4. The end of an era? Branding horses does not enable them to be identified
5. Bend or stretch? How stressful is hyperflexion of horses necks?
6. New study evaluates noninvasive technology to determine heart disease
7. Zebrafish study explains why the circadian rhythm affects your health
8. University of Tennessee Team receives NSF support to study toxic water in China
9. Imaging study sheds new light on alcohol-related birth defects
10. Iowa State, Ames Lab researchers study the structure of drug resistance in tuberculosis
11. Study shows long-term effects of radiation in pediatric cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4The secret of DNA methylation 2
... us to spot prey, vision keeps many animals, including humans, ... why is it easier for us to spot movement of ... other things? The complexity of the neural network that supports ... technology and support from the National Science Foundation, Claire Wyart ...
... Calif., November 1, 2010 One of the many advantages ... which in turn supports a healthy heart. Fat tissue is ... it,s also an active secretory organ that normally produces high ... the hearts of healthy people has long been a mystery, ...
... developing a cost-effective electronic monitoring system that will enable ... by allowing users to track water-quality data from these ... National Science Foundation (NSF) grant. "Our goal is ... conditions in the Chesapeake Bay, the sounds of North ...
Cached Biology News:The zebrafish's neural circuit prevents it from biting off more than it can chew 2Study finds fat hormone's long-sought link to heart protection 2Researchers developing real-time electronic monitoring for coastal waters 2
(Date:6/19/2013)... , June 19, 2013 Synthetic Biologics, Inc. (NYSE ... and treatment of serious infectious diseases, announced today that ... Annual OneMedForum New York Conference on Thursday, June 27, ... City . Mr. Riley is scheduled to present at ... Synthetic Biologics, presentation can be accessed by logging onto the ...
(Date:6/19/2013)...   NineSigma , Inc., of Cleveland ... launch, NineSights.com is now the innovation engine ... worldwide community of innovators. From technology developers, ... NineSights stands out for its large community of innovators ... disciplines, all vetted by NineSigma. The community is free ...
(Date:6/19/2013)... Biotechnology industry pioneer Amgen (NASDAQ: AMGN ... Systems  and enterprise application software leader SAP AG ... week entitled "No Account Left Behind!  Learn ... Keep Its Account Reconciliations in Good Shape ."    ... webinar, geared at finance, accounting, audit and compliance managers in ...
(Date:6/19/2013)... 2013 India’s vast and growing ... be worth up to a billion dollars per ... government is taking serious action to better regulate ... This presentation will examine:, ,     Recent ...     Immediate and long term impacts ,     Foreseeable ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4
... -. Actavis Group, the,international generic pharmaceuticals company, has ... Food & Drug,Administration. Distribution of the product will ... equivalent to Pfizer,s,Camptosar(R) will be available in 40 ... and is,used in the treatment of patients with ...
... CryoCath,s Cryoablation System, SAN DIEGO, Feb. 28 ... focused on the treatment of cardiac,arrhythmias, announced today ... the,United States International Trade Commission (ITC) alleging that ... by infringing on,several CryoCor patents with its cryoablation ...
... Johnson, Jr. Resigns as President and Chief Executive ... Opportunities, HAYWARD, Calif., Feb. 28 Kosan ... Robert G. Johnson, Jr.,M.D., Ph.D., has resigned as ... Kosan,s Board of Directors. Helen S. Kim, who ...
Cached Biology Technology:Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 2CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement 3Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 2Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 3Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 4Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 5Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 6Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 7Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 8
...
... Solid phase reagent ... purification; Easy & unique ... Compatible with detergents and ... & recover non-envelop viruses ...
Synaptic Vesicle I Sampler Kit 10g each...
Mouse monoclonal [3A7.A11] to Thymidylate Synthase ( Abpromise for all tested applications). entrezGeneID: 7298 SwissProtID: P04818...
Biology Products: